Khaled Musallam/LinkedIn
Sep 2, 2026, 14:28
Khaled Musallam: The 5th MENA Congress for Rare Diseases Is Coming to Abu Dhabi
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared a post on LinkedIn:
“Looking forward to the 5th MENA Congress for Rare Diseases, taking place 3–5 September in Abu Dhabi.
Pleased to contribute across three exciting areas – chairing the 2nd MENA Summit for Gene and Cell Therapy, chairing and speaking in the rare immune and blood disorders session, and chairing AI, research, and innovation in rare diseases.
Three days bringing together science, innovation, and collaboration to advance care for people living with rare diseases.”
Find more posts featuring Khaled Musallam on Hemostasis Today.
-
Sep 3, 2026, 00:44Same goal, Different molecular strategy – Which FVIIIa Mimetic Gets There How? – RPTH Journal
-
Sep 3, 2026, 00:33Hannah Isles: Interesting Link between Aging, Serotonin, Platelets and COVID-19 Severity
-
Sep 3, 2026, 00:22Danny Hsu: Paradigm Shift in PE Management? – Unpacking the PRAGUE-26 Trial
-
Sep 3, 2026, 00:14Leonardo Roever: Antiphospholipid Antibodies Present in 19% of Ischemic Stroke Cases
-
Sep 3, 2026, 00:03Jochebed Adwoa Sutherland: First Reported Case of Breast Mondor’s Disease in a Patient Living with Sickle Cell
-
Sep 2, 2026, 23:50Shashank Joshi: Individualized vs. Standard BP Control Shows Similar 90-Day Outcomes
-
Sep 2, 2026, 18:26Strengthening Comprehensive Care for Inherited Bleeding Disorders in Ecuador – World Federation of Hemophilia
-
Sep 2, 2026, 18:24Zeeshan Ahmed Khattak: Managing Febrile Neutropenia in Hematology/Oncology and Transplant Patients
-
Sep 2, 2026, 18:22Mark Heyland: The Role of Thromboinflammation in Fracture Non-Union